Patents by Inventor Marc Awobuluyi

Marc Awobuluyi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Excitatory glycine receptors and methods
    Patent number: 8193315
    Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: June 5, 2012
    Assignees: Sanford-Burnham Medical Research Institute, Yale University, The Brigham and Women's Hospital, Inc.
    Inventors: Stuart A. Lipton, Dongxian Zhang, Jon E. Chatterton, Kevin A. Sevarino, Marc Awobuluyi
  • EXCITATORY GLYCINE RECEPTORS AND METHODS
    Publication number: 20110045098
    Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.
    Type: Application
    Filed: July 23, 2010
    Publication date: February 24, 2011
    Applicants: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE, THE BRIGHAM AND WOMEN'S HOSPITAL, INC., YALE UNIVERSITY
    Inventors: STUART A. LIPTON, DONGXIAN ZHANG, JON E. CHATTERTON, KEVIN A. SEVARINO, MARC AWOBULUYI
  • Excitatory glycine receptors and methods
    Patent number: 7790404
    Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: September 7, 2010
    Assignees: Sanford-Burnham Medical Research Institute, Yale University, The Brigham and Women's Hospital, Inc.
    Inventors: Stuart A. Lipton, Dongxian Zhang, Jon E. Chatterton, Kevin A Sevarino, Marc Awobuluyi
  • Excitatory glycine receptors and methods
    Publication number: 20040033500
    Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.
    Type: Application
    Filed: August 16, 2002
    Publication date: February 19, 2004
    Applicants: The Burnham Institute, The Brigham and Womens Hospital, Inc.
    Inventors: Stuart A. Lipton, Dongxian Zhang, Jon E. Chatterton, Kevin A. Sevarino, Marc Awobuluyi
  • Excitatory glycine receptors and methods
    Publication number: 20030092004
    Abstract: The invention provides isolated NR3B polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.
    Type: Application
    Filed: August 20, 2001
    Publication date: May 15, 2003
    Inventors: Stuart A. Lipton, Dongxian Zhang, Jon E. Chatterton, Marc Awobuluyi, Kevin A. Sevarino